Register Now for SUD Webinar on Future Directions, Long-Acting Injectables, and Novel Therapies
(Part 6 of 6) Substance Use Disorder: Future Directions, Long-Acting Injectables, and Novel Therapies
Wednesday, January 24, 2024
2:00 PM – 3:30 PM Pacific Time
The IAS–USA is excited to support you in meeting the new Drug Enforcement Agency MATE Act requirements with a free webinar series comprising 8 hours of training to help you provide the best possible care for your HIV patients! Don’t miss the final webinar in the series, which is presented by Michelle R. Lofwall, MD, and moderated by Ellen F. Eaton, MD, and discusses future directions in the treatment of SUD on HIV-related morbidity and mortality, including the management of long-acting injectable therapy for opioid use disorder.
Register here: https://www.iasusa.org/events/webinar-2024-lofwall-eaton-part-6/
Continuing Education Credits
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.